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j ourna l homepage: ht tp : / /www.sch iz rescogn i t ion.com/Editorial LetterIt ismypleasure to present this special section that reports thework of
some of the most relevant Spanish research groups on Cognition and
Schizophrenia. All of the teams have considerable international experi-
ence with leading lines of research in the topics. I want to thank the
authors for their generosity in agreeing to publish theseworks in Spanish,
despite all of them having enough quality to be published in English and
therefore having a higher international impact in that language. The
objective of this number is to reach the maximum dissemination of the
ideas, not only among researchers but also among clinicians and students,
facilitating their acquisition and implementation.
The ﬁrst of the 4 studies presented, authored by Dr Penadés and Dr
Bernardo, is a comprehensive review on biomarkers of cognitive
impairment in schizophrenia that deepens the scientiﬁc evidence that
supports the relationships. This research group, located at the Clinic
Hospital of Barcelona, has accumulated a long trajectory of research
on biomarkers, with a wide range of publications on neuroimaging,
genetics, inﬂammatory factors, etc, in schizophrenia, that have been
reported in prestigious international journals.
The second study, authored by Dr López, is entitled “The inﬂuence
of the polymorphism Val158Met COMT in context processing in
patients with schizophrenia spectrum disorders and their relatives.”
This article evaluates the relationship between genetic predisposi-
tions to the disease, the presence of polymorphism COMT, its role in
the regulation of dopamine levels, and the difﬁculty of patients to
perform an effective identiﬁcation and processing of cognitive stimuli
in a speciﬁc context.http://dx.doi.org/10.1016/j.scog.2015.11.005
2215-0013/© 2015 Published by Elsevier Inc.DrOrtuño and his research group at the Clinic University of Navarra
give us a review focused on a novel idea barely discussed in the past
literature. His research group is one of the world leaders in the idea
that patientswith schizophrenia present an altered perception of time,
how time runs, how long each action lasts, and theway to correctly and
a priori estimate the time needed to achieve an objective. The authors
review the evidence about the neuroanatomical basis of this cognitive
process and argue about the relationship between the deﬁcit and the
erratic functioning of the patients in their daily life.
Finally, the study that brings this monograph to a close is the result
of collaboration among diverse national institutions: Psychiatric
Hospital from Alava, Hospitals from Madrid, “Puerta del Hierro”
Hospital, and University of Deusto. This randomized clinical trial
evaluates the efﬁcacy of a novel method of cognitive intervention,
based on the cinema: a functional and entertaining activity rooted in
the daily life of the population. Through a standardized method based
on television show The Soprano's, cognitive, clinical, and functional
changes are investigated at posttreatment.
I invite you to this special section and let us embark together through
this path, starting on the identiﬁcation of useful biomarkers to help in
the prompt diagnosis of the disease and its cognitive deﬁcits, and
ﬁnishing with the most novel approaches for therapeutic strategies.
Sincerely,
Dr. Natalia Ojeda del Pozo
